COMMUNIQUÉ DE PRESSE publié le 16/09/2025 à 10:00, il y a 7 mois 2 jours aap Implantate AG closes the first half of the year with sales of € 6.2 million; clinical trial nears positive conclusion aap Implantate AG reports €6.2 million sales in the first half of 2025, with clinical trial near positive conclusion. Regional growth in EMEA, strong performance in APAC, US tariff impact mitigated Sales Clinical Trial Aap Implantate AG US Tariffs Regional Growth
BRÈVE publiée le 09/09/2025 à 15:05, il y a 7 mois 9 jours Aap Implantate AG achève un essai clinique pour sa technologie antibactérienne Opportunités D'investissement Essai Clinique Approbations Réglementaires Économies Sur Les Soins De Santé Technologie Antibactérienne
BRÈVE publiée le 09/09/2025 à 15:05, il y a 7 mois 9 jours Aap Implantate AG Completes Clinical Trial for Antibacterial Technology Investment Opportunities Clinical Trial Regulatory Approvals Healthcare Savings Antibacterial Technology
COMMUNIQUÉ DE PRESSE publié le 09/09/2025 à 15:00, il y a 7 mois 9 jours aap successfully completes human clinical trial for antibacterial surface technology aap Implantate AG successfully completes human clinical trial for antibacterial surface technology with positive results, expecting MDR and US FDA approval. Study report due by end of 2025 Clinical Trial Aap Implantate AG Antibacterial Surface Technology MDR Approval US FDA Approval
BRÈVE publiée le 01/08/2025 à 12:20, il y a 8 mois 17 jours Aap Implantate AG Shares Gain Full Market Admission Frankfurt Stock Exchange Aap Implantate AG Regulated Market Lock-up Agreements ISIN DE000A3H2101
BRÈVE publiée le 01/08/2025 à 12:20, il y a 8 mois 17 jours Les actions d’aap Implantate AG bénéficient d’une admission complète sur le marché Marché Réglementé Aap Implantate AG Bourse De Francfort ISIN DE000A3H2101 Accords De Blocage
COMMUNIQUÉ DE PRESSE publié le 01/08/2025 à 12:15, il y a 8 mois 17 jours aap Implantate AG: Full admission of all previously unadmitted shares, introduction to stock exchange trading and termination of lock-up agreements aap Implantate AG announces full admission of previously unadmitted shares to the Frankfurt Stock Exchange's regulated market, along with the termination of lock-up agreements Shareholders Frankfurt Stock Exchange Aap Implantate AG Regulated Market Traumatology
BRÈVE publiée le 21/07/2025 à 21:00, il y a 8 mois 28 jours Aap Implantate AG Reports 2024 Financial Results: Strong Operational Gains Growth Strategy Financial Results Operational Improvement Equity Ratio 2024 Audit
BRÈVE publiée le 21/07/2025 à 21:00, il y a 8 mois 28 jours Aap Implantate AG publie ses résultats financiers pour 2024 : solides gains opérationnels Résultats Financiers Stratégie De Croissance Amélioration Opérationnelle Ratio De Fonds Propres Audit 2024
COMMUNIQUÉ DE PRESSE publié le 21/07/2025 à 20:55, il y a 8 mois 28 jours aap Implantate AG publishes final audited consolidated financial statements 2024 - confirmation of strong operational improvement aap Implantate AG publishes final audited consolidated financial statements 2024, confirming strong operational improvement. The company achieved a significant increase in Group EBITDA Financial Performance Operational Improvement Aap Implantate AG Audited Financial Statements Group EBITDA
Publié le 17/04/2026 à 20:30, il y a 1 jour 13 heures ALTAREA - Déclaration d’opérations sur actions propres
Publié le 17/04/2026 à 19:00, il y a 1 jour 14 heures Cegedim : Publication du Document d’Enregistrement Universel 2025
Publié le 17/04/2026 à 19:00, il y a 1 jour 14 heures Cegedim: Release of its 2025 Universal Registration Document
Publié le 17/04/2026 à 17:45, il y a 1 jour 16 heures Carrefour announces the sale of its minority stake in CarrefourSA in Turkey to Aydın
Publié le 17/04/2026 à 17:45, il y a 1 jour 16 heures Carrefour annonce la cession de sa participation minoritaire dans CarrefourSA en Turquie à Aydın
Publié le 18/04/2026 à 04:00, il y a 1 jour 5 heures Formation Metals Responds to OTC Markets Request on Recent Promotional Activity
Publié le 18/04/2026 à 02:00, il y a 1 jour 7 heures AI/ML Innovations Announces Completion of Share Issuance
Publié le 18/04/2026 à 01:35, il y a 1 jour 8 heures Medicure Announces Resignation of President and Chief Operating Officer
Publié le 18/04/2026 à 01:00, il y a 1 jour 8 heures Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Publié le 18/04/2026 à 00:00, il y a 1 jour 9 heures Redwood AI Announces Collaboration with Aidos Innovations, Aimed at Enhancing Public Safety Collaboration with B.C. Government, Canadian Federal and Local Law Enforcement Agencies to Tackle the Fentanyl Crisis in British Columbia
Publié le 18/04/2026 à 00:05, il y a 1 jour 9 heures ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
Publié le 17/04/2026 à 21:39, il y a 1 jour 12 heures Linedata Services: Mise à disposition du Document d’Enregistrement Universel 2025 incluant le Rapport Financier Annuel 2025
Publié le 17/04/2026 à 20:33, il y a 1 jour 13 heures LLB General Meeting 2026 – Shareholders approve all proposals of the Board of Directors
Publié le 17/04/2026 à 19:30, il y a 1 jour 14 heures KAP AG: REFINANCING CONCEPT AGREED; NEW SYNDICATED LOAN SECURES FLEXIBILITY FOR THE ONGOING TRANSFORMATION PROCESS